CCC

Cadrenal Therapeutics, Inc.

No trades
See on Supercharts

Price target

52.500.000.00%
The 2 analysts offering 1 year price forecasts for CVKD have a max estimate of — and a min estimate of —.

Analyst rating

Based on 2 analysts giving stock ratings to CVKD in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


CVKD EPS for the last quarter is −2.25 USD despite the estimation of −1.27 USD. In the next quarter EPS is expected to reach −1.93 USD. Track more of Cadrenal Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Cadrenal Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out Cadrenal Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, CVKD price target is 52.50 USD with a max estimate of 60.00 USD and a min estimate of 45.00 USD. Check if this forecast comes true in a year, meanwhile watch Cadrenal Therapeutics, Inc. stock price chart and keep track of the current situation with CVKD news and stock market news.